Topoisomerase Assays

John L Nitiss1, Kostantin Kiianitsa2, Yilun Sun3

  • 1Pharmaceutical Sciences Department, University of Illinois College of Pharmacy, Rockford, Illinois.

Current Protocols
|October 4, 2021
PubMed

Insights

This study provides protocols to measure DNA topoisomerase activity and their inhibitors, crucial for developing anti-cancer therapies. These methods assess enzyme function and DNA-protein complexes for broader applications in characterizing DNA adducts.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Topoisomerases are essential enzymes regulating DNA topology during replication, transcription, and segregation.
  • Type I and Type II topoisomerases perform distinct DNA cleavage and ligation functions.
  • These enzymes are validated targets for anti-cancer drug development.

Purpose of the Study:

  • To present detailed protocols for assessing DNA topoisomerase activities and their inhibitors.
  • To describe methods for quantifying topoisomerase-DNA covalent complexes.
  • To explore the utility of these approaches for characterizing other DNA-protein adducts.

Main Methods:

  • Assays for topoisomerase I (DNA relaxation) and topoisomerase II (DNA decatenation) activity.
  • In vivo complex of enzyme (ICE) assay for determining topoisomerase covalent complexes.
  • Rapid approach to DNA adduct recovery (RADAR) combined with ELISA or Western blot for quantification.
  • DNA cleavage assays, including plasmid linearization and gel electrophoresis.

Main Results:

  • Established protocols enable robust measurement of topoisomerase I and II activities.
  • Methods for enriching and quantifying topoisomerase-DNA covalent complexes were detailed.
  • Assays for DNA cleavage by topoisomerases were optimized.
  • The described techniques are adaptable for characterizing diverse DNA-protein adducts.

Conclusions:

  • The provided protocols offer comprehensive tools for studying topoisomerase function and inhibition.
  • These methods facilitate the discovery and development of novel anti-cancer agents targeting topoisomerases.
  • The adaptable techniques can advance the characterization of various DNA-protein interactions and therapeutic targets.